IMAB NASDAQ
I-Mab
1W: +5.1%
1M: +8.2%
3M: +23.3%
1Y: +370.2%
3Y: +19.9%
5Y: -89.5%
$2.88
Last traded 2025-12-26 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
0.00
Neutral
0 bullish
0 neutral
0 bearish
Articles (24h)
0
No articles in the last 24 hours
0.00
Neutral
0 bullish
1 neutral
0 bearish
Articles (7d)
1
Daily Sentiment (7 Days)
Articles (13)
Reviewing I-Mab (NASDAQ:NBP) & Valion Bio, Inc. Common Stock (NASDAQ:VBIO)
Reviewing I-Mab (NASDAQ:NBP) and Relay Therapeutics (NASDAQ:RLAY)
I-Mab (NASDAQ:NBP) Stock Rating Upgraded by Wall Street Zen
Wall Street Zen Downgrades I-Mab (NASDAQ:NBP) to Strong Sell
Research Analysts Offer Predictions for I-Mab Q3 Earnings
I-Mab (NASDAQ:NBP) Receives Buy Rating from HC Wainwright
I-Mab (NASDAQ:NBP) Trading Down 4.9% – Time to Sell?
I-Mab (NASDAQ:NBP) Lowered to “Sell” Rating by Wall Street Zen
HC Wainwright Has Negative Outlook for I-Mab Q1 Earnings
I-Mab (NASDAQ:NBP) Receives “Buy” Rating from HC Wainwright
Wall Street Zen Downgrades I-Mab (NASDAQ:NBP) to Hold
I-Mab (NASDAQ:NBP) Given “Buy” Rating at HC Wainwright
I-Mab (NASDAQ:NBP) Shares Up 5.2% – Still a Buy?